Evaluation of immunogenicity, safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children
Background: In India, where varicella outbreaks are reported at a younger age, a two-dose vaccine schedule administered at an early age could be highly efficacious in preventing varicella infection. The aim of this study was to evaluate the immunogenicity and safety of live attenuated varicella vacc...
Saved in:
Main Authors: | Monjori Mitra (Author), Jaydeep Chowdhury (Author), Surupa Basu (Author), Partha Pratim Halder (Author), Mallar Mukherjee (Author), Archana Karadkhele (Author), Gaurav Puppalwar (Author), Rishi Jain (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of long term immunogenicity and tolerability of live hepatitis A vaccine
by: Nitin Shah, et al.
Published: (2020) -
Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial
by: Anand Prakash Dubey, et al.
Published: (2017) -
Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review
by: Jessica Leung, et al.
Published: (2017) -
Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks
by: Wei Qin, et al.
Published: (2020) -
A BREAKTHROUGH VARICELLA: WILL A NEW VACCINATION SCHEDULE CHANGE THE SITUATION?
by: E.A. Vishneva, et al.
Published: (2011)